Position in ZTS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$30,853,522
-$91,736,158 QoQ
Shares Held
429,356
-58.6% QoQ
Ownership
0.104%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#124
of 1,408 holders
Holding Since
Sep 2020
6 quarters on record
Voting authority
Sole 71%
Shared 0%
None 29%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026JUPITER ASSET MANAGEMENT LTD holds $164,709,425 across 6 Drug Manufacturers - Specialty & Generic names. ZTS ranks #2 (18.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
4,219,279 | $103,836,455 | |
| 2 | ZTS |
Zoetis Inc.
This page
|
429,356 | $30,853,522 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,642,874 | $16,428,740 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
197,149 | $8,089,022 | |
| 5 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
274,944 | $4,937,994 | |
| 6 | VTRS |
Viatris Inc
|
35,497 | $563,692 |
All Filings in ZTS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30,853,522 | 429,356 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $122,589,680 | 1,037,050 | Shares | Defined | 2026-05-12 | |
| 2025-09-30 | $57,949,011 | 396,043 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $65,926,770 | 422,743 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $2,278,426 | 13,838 | Shares | Sole | 2025-05-09 | |
| 2020-09-30 | $242,597 | 1,467 | Shares | Defined | 2020-11-10 | |
| No filing history on record for this holder in this stock. | ||||||